Aldeyra Therapeutics, Inc.(ALDX)- NASDAQ
  • wilkinson99 | Send Message 9 Aug

    Top % Gainers: $REN 29%, $WAC 25%, $MWW 23%, $WPRT 22%, $GSV 22%, $SPEX 19%, $CSLT $HIIQ $ENDP $FCSC $ALDX $PLM $EGRX $VSLR $VRX $NVRO $IPHI
    Reply
      • wilkinson99 | Send Message 9 Aug

        Premarket Top % Gainers: $HIIQ 35%, $MWW 23%, $WPRT 20%, $ALDX 19%, $FH 17%, $GSV $VII $SPEX $REN $WAC $ENDP $CSLT $VSLR $SIEN $AMFW $NVRO
        Reply
          • wilkinson99 | Send Message 9 Aug

            Premarket Top % Gainers: $HIIQ 48%, $ALDX 41%, $GBSN 30%, $MWW 22%, $REN 17%, $VRX 9% $AMFW $IMNP $VSLR $ENDP $ISNS $KNDI $PRAN $APOP $DGAZ
            Reply
              • Societe Financiers | Send Message 3 Jun

                Exclusive: Aldeyra CEO Todd Brady Talks Drug Potential, Cash & New Talent: http://bit.ly/030616ALDX $ALDX
                Reply
                  • Alexander Valtsev | Send Message 3 Jun

                    Exclusive: Aldeyra CEO Todd Brady Talks Drug Potential, Cash & New Talent: http://bit.ly/030616ALDX $ALDX
                    Reply
                      • wilkinson99 | Send Message 29 Feb

                        Top % Gainers: $ATNY 93%, $FDML 45%, $SALT 44%, $ALDX 35%, $ENPH 31%, $GSI 31%, $GLBL 25%, $CAIXY 24%, $BSFT $SDRL $EPE $BIOC $CLNE $ELMD
                        Reply (1)
                        • X Oil-Field | Send Message 9 Mar
                          : Shippers withdraw [capacity] dry-bulkers to support rates, more requests to that effect have been submitted. (BDI) at 376.00. #Gainers
                          • wilkinson99 | Send Message 29 Feb

                            Top % Gainers: $ATNY 93%, $FDML 50%, $ALDX 37%, $BSFT 19%, $GSI 16%, $DGAZ 13%, $TASR 13%, $ELMD $SIG $ARGS $KERX $TRCO $MHGC $BRZU $OVAS
                            Reply
                              • wilkinson99 | Send Message 29 Feb

                                Top % Gainers: $ATNY 93%, $FSML 49%, $ALDX 28%, $BSFT 19%, $GSI 16%, $DGAZ 13%, $TASR 13%, $ELMD $SIG $ARGS $KERX $TRCO $MHGC $BRZU $OVAS
                                Reply
                                  • Kanak Kanti De | Send Message 8 Dec 2015

                                    Interview And Panel Discussion With Aldeyra CEO Dr. Todd C. Brady $ALDX http://seekingalpha.com/a/286rs
                                    Reply
                                      • Kanak Kanti De | Send Message 1 Dec 2015

                                        Aldeyra: Small Pharma, Smart Pipeline, Acquisition Potential $ALDX http://seekingalpha.com/a/27ogm
                                        Reply
                                          Company Description
                                          Aldeyra Therapeutics, Inc. operates as a biotechnology company. It is primarily focused on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States